News

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal

30-09-2013

Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

Mylan debuts generic Antara; FDA approves generics of Actavis' Suboxone, Lupin's Suprax and Zydus' Zantac

25-02-2013

US generic firm Mylan (Nasdaq: MYL) says its subsidiary Mylan Pharmaceuticals has begun shipping fenofibrate…

ActavisAntaraAntibiotics and Infectious diseasesCardio-vascularGastro-intestinalsGenericsLupinMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaRegulationSuboxoneSupraxZantacZydus Cadila

South Africa awards 5.9 billion-rand antivirals tender; Panacela Russian contract

29-11-2012

The South African government has announced a 5.9 billion rand ($665 million) tender awarded to three…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesBiotechnologyCipla MedproCleveland BioLabsFinancialGeneralMylan LaboratoriesPanacela LabsRest of the WorldXenomycins

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

01-05-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

PDL BioPharma to pay MedImmune $92.5 million to resolve patent disputes; Mylan debuts generic Vfend

17-02-2011

PDL BioPharma (Nasdaq: PDLI) saw its shares drop 3.5% to $5.25 after the company said it had entered…

Antibiotics and Infectious diseasesAstraZenecaFinancialGenericsMedImmuneMylan LaboratoriesNorth AmericaPatentsPDL BioPharmaPfizerPharmaceuticalRespiratory and PulmonarySynagisVfend

COMPANY SPOTLIGHT

Menarini

Back to top